Assignee
XEME BIOPHARMA INC
US·1 granted patent·3 pending applications·0 citations·filing 2017–2020
Top patents by PatentIndex Score
4 records- 0157US11766473B2Therapeutic cancer vaccine containing tumor-associated neoantigens and immunostimulants in a deliver systemXEME BIOPHARMA INC·Filed 2020·Granted Sep 26, 2023·0 cites·8 claims
- 0256US2020054726A1Cancer therapy using a vaccine in combination with a cell-based immunotherapeutic agentXEME BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 0347US2017224796A1Therapeutic Cancer Vaccine Containing Tumor-Associated Neoantigens and Immunostimulants in a Delivery SystemXEME BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 0446US2017224797A1Cancer Therapy Using a Vaccine in Combination with a Cell-Based Immunotherapeutic AgentXEME BIOPHARMA INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when XEME BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →